Site Search

Displaying results 11 - 20 of 99

EBOMAN

Manufacturing and development for rapid access Ebola vaccine

PRIMAVERA

Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance

Ongoing IMI2 Antimicrobial resistance Infectious diseases Vaccines Biologicals AMR Accelerator Economic model

Close-up of a band aid on the upper arm. Image courtesy of Chanita Chokchaikul via Shutterstock

09/12/2021

With multiple flu vaccines on offer, how do doctors choose?

DRIVE found fewer options for older people, and that younger people’s other risk factors play a part in the choice. This data is helping calculate the effectiveness of vaccination...

An illustration of the influenza virus. Image by Kateryna Kon via Shutterstock.

30/05/2022

How a project to gather data on flu vaccines is helping to improve Europe’s pandemic response

For the majority of people, vaccines have always been a part of our lives; we didn’t think about how they are developed or the diseases they control. However, the coronavirus...

03/12/2021

Partners

IHI is a public-private partnership (PPP) between the EU and Europe’s health industries.

Inno4Vac

Innovations to accelerate vaccine development and manufacture

Ongoing IMI2 Infectious diseases Vaccines Tools for predicting/monitoring efficacy Big data and knowledge management Artificial intelligence

13/06/2023 15:00 - 16:30

IMI impact on Ebola

This online event focused on how Innovative Medicines Initiative (IMI) projects are delivering results to advance the development and uptake of Ebola vaccines.